Email Us
View Reports

Precision Medicine Software Market

Precision Medicine Software Market Analysis - By Technology (Big Data Analytics, Bioinformatics, Genetic Sequencing, Drug Discovery & Associated Diagnosis), By Application (Oncology, Respiratory, Immunology & Central Nervous System), By End-User (Pharmaceutical Companies, Diagnostic Companies & Computer Companies), By Region (North America (United States & Canada), Europe (United Kingdom, Italy, Germany, Spain, France & Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Mexico, Argentina & Rest of Latin America), Middle East & Africa) - Industry Size, Share, Trends, Growth & Forecast Report | 2019 - 2025

  • ID : 1128503666  |  
  • Published : Oct-2019  |  
  • Region : Global  |  
  • Pages : 100   |  
  • Publisher : Acute Market Insights

Precision Medicine Software Market Size, Growth Rate & Forecast (2019 - 2025)

According to the Research Report, the Global Precision Medicine Software Market is expected to be reached at 1.19 billion in 2019 and to have a CAGR of 11.45% over the forecast period 2019 - 2025.

 Key Growth Drivers

  • Recent advances in Big Data technology applications for accurate disease detection will have a positive impact on the market's revenues over the forecast period. In addition, the introduction of software with an improved clinical workflow will likely increase the ability to store a large amount of genetic data to ensure rapid patient recovery. This, in turn, will stimulate the growth of the precision medicine software market in the coming years. In addition, software specifically designed to develop precision drugs used in the treatment of chronic diseases, as well as genetic diseases ensuring rapid patient recovery, will increase the size of the market in the coming years. The growing acceptance of big data analysis and sequencing of gene therapy genes will increase the growth of the market in the near future.

  • Expenses have increased the levels of expenditure that cause the need for effective diagnostic procedures for cancer. The greater use of complex biomarkers for the increase in the prevalence and diagnosis of cancer are some of the factors that are expected to promote the precision medicine software market growth. The market was also introduced to improve the clinical workflow, and it will increase the likelihood that large amounts of genetic information may be stored in order to guarantee the rapid recovery of the patient, which can stimulate the growth of the precision medicine software market.

  • The main factor in the market includes the development of a new generation of minor sequencing clinics, the technology of the entire genome, diagnosis and accompanied augmentation. Due to a genetic illness to ensure the rapid recovery of the patient and the software developed especially for precise drugs used in the treatment of chronic diseases, it is expected to have huge future development of the market. With the growth of the precision medicine software market, greater precision in the near future such as the analysis of large data and gene therapy to increase the acceptance of gene sequencing increases.

Factors Limiting the Growth of the Market:

However, violating the rules of confidentiality and misinterpreting genetic and health information can damage the growth of this business. Companies in the most important industries focus on software updates and market opportunities in the future to support the drug development process in precision medicine.

Key Take-Aways from this Report:

  • For different product types, end-use applications and industry verticals, offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate the Precision Medicine Software Market potential.
  • Identify various driving factors, constraints and untold opportunities that can impact the global Precision Medicine Software Marketplace
  • Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
  • Increase overall revenue by understanding the geographical impact on sales and distribution channels.
  • Evaluate the increase in values at each step of the industry supply chain to improve process efficiency and optimize the value.
  • Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
  • Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the worldwide Precision Medicine Software Market in over 20 top nations.

The Research Report segments the Global Precision Medicine Software Market into the following submarkets:

Global Precision Medicine Software Market – By technology 

  • Big Data Analytics
  • Bioinformatics
  • Genetic Sequencing
  • Drug Discovery
  • Associated Diagnoses

Global Precision Medicine Software Market - By Application

  • Oncology
  • Respiratory
  • Immunology
  • Central nervous system

Global Precision Medicine Software Market - By End-User

  • Pharmaceutical companies
  • Diagnostic companies
  • Computer companies

Global Precision Medicine Software Market – By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Depending on the region, the world market for precision medicine software can be divided into five main regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The North American market is expected to experience strong growth over the forecast period. This growth can be attributed to the increase in the geriatric population suffering from chronic diseases such as cancer. The market for precision medicine software in the Asia Pacific is expected to grow over the next few years. The growing burden of genetic diseases in China will stimulate the demand for genetic therapies in the Asia Pacific.

Some of the Promising Companies Operating the Global Precision Medicine Software Market Profiled in the Report are:

  1. Syapse, Inc
  2. 2bPrecise LLC
  3. Foundation Medicine, Inc.
  4. Fabric Genomics
  5. Sophia GENETICS SA
  6. Abbott Laboratories
  7. GE Healthcare
  8. GlaxoSmithKline (GSK)
  9. Johnson & Johnson
  10. Pfizer
  11. Laboratories Corporation of America Holdings
  12. Danaher Corporation

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency 

    1.5 Limitations 

    1.6 Stakeholders

2 Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Data

                    2.1.1.1 Secondary Sources

           2.1.2 Primary Data

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Breakdown of Primaries

                    2.1.2.3 Key Industry Insights

    2.2 Market Size Estimation 

    2.3 Market Breakdown and Data Triangulation 

    2.4 Assumptions for the Study

3 Executive Summary 

4 Premium Insights

    4.1 Precision Medicine Software: Market Overview 

    4.2 Geographic Analysis: North American Precision Medicine Software Market, By Delivery Mode 

    4.3 Us Precision Medicine Software Market 

    4.4 Geographical Snapshot of the Precision Medicine Software Market

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Rising Government Funding in Precision Medicine Initiatives

                    5.2.1.2 Partnerships Among Pharmaceutical and Software Companies

                    5.2.1.3 Entry of New Players and Vc Funding

                    5.2.1.4 Growth in the Number of Cancer Patients

           5.2.2 Restraints

                    5.2.2.1 High Cost of Deployment

           5.2.3 Opportunities

                    5.2.3.1 Emerging Countries

                    5.2.3.2 Cloud-Based Solutions

                    5.2.3.3 Artificial Intelligence in Precision Medicine

           5.2.4 Challenges

                    5.2.4.1 Secure Storage of Large Volumes of Sequenced Data

                    5.2.4.2 Lack of Reimbursement for Precision Medicine-Based Treatments

                    5.2.4.3 Lack of Skilled It Professionals in Healthcare

6 Precision Medicine Software Market, By Delivery Mode

    6.1 Introduction 

    6.2 On-Premise Delivery Mode 

           6.2.1 Benefits Offered By the On-Premise Delivery Model and Limited Penetration of Cloud-Based Technologies to Drive Market Growth

    6.3 Cloud-Based Delivery Mode 

           6.3.1 Open-Access Nature of Cloud-Based Models Poses Security Challenges

7 Precision Medicine Software Market, By End User

   7.1 Introduction 

    7.2 Healthcare Providers 

           7.2.1 Precision Medicine is Used By Healthcare Providers to Determine Disease Susceptibility and Provide Personalized Treatments

    7.3 Research Centers and Government Institutes 

           7.3.1 Increasing Funding for Research Will Drive the Usage and Adoption of Precision Medicine Software in This Segment

    7.4 Pharmaceutical & Biotechnology Companies 

           7.4.1 Increasing Emphasis on Pharmacogenomics Due to Its Applications in Drug Development is to Drive Market Growth

    7.5 Other End Users

8 Precision Medicine Software Market, By Application

    8.1 Introduction 

    8.2 Oncology 

           8.2.1 Oncology Segment to Witness the Highest Growth in the Precision Medicine Software Market

    8.3 Pharmacogenomics 

           8.3.1 Pharmacogenomics is A Potential Solution to Reduce Healthcare Costs Associated With Ades and Poor Response to Pharmacotherapy

    8.4 Rare Diseases 

           8.4.1 Increasing Incidence of Rare Diseases to Drive Market Growth

    8.5 Other Applications

9 Precision Medicine Software Market, By Region

    9.1 Introduction 

    9.2 North America 

           9.2.1 US

                    9.2.1.1 Government Funding to Support Market Growth in the US

           9.2.2 Canada

                    9.2.2.1 Rising Incidence of Cancer in Canada Will Drive the Demand for Precision Medicine Software

    9.3 Europe 

           9.3.1 Eu5

                    9.3.1.1 Favorable Funding Scenario Will Support Market Growth in Eu5

           9.3.2 Rest of Europe

    9.4 Asia 

           9.4.1 Growing Research Investments in China, Japan & India Will Contribute to Market Growth in Asia

    9.5 Rest of the World

10 Competitive Landscape

     10.1 Overview 

     10.2 Market Ranking of Players, 2018 

     10.3 Competitive Leadership Mapping 

             10.3.1 Visionary Leaders

             10.3.2 Innovators

             10.3.3 Dynamic Differentiators

             10.3.4 Emerging Companies

     10.4 Competitive Scenario 

             10.4.1 Solution Launches

             10.4.2 Expansions

             10.4.3 Partnerships, Agreements, and Collaborations

             10.4.4 Acquisitions

11 Company Profiles 

     11.1 Syapse, Inc. 

     11.2 2bprecise, LLC 

     11.3 Fabric Genomics, Inc. 

     11.4 Foundation Medicine, Inc. 

     11.5 Sophia Genetics Sa 

     11.6 Pieriandx, Inc. 

     11.7 N-Of-One, Inc. (A Subsidiary of Qiagen N.V.) 

     11.8 Human Longevity, Inc. 

     11.9 Translational Software Inc. 

     11.10 Sunquest Information Systems, Inc. 

     11.11 Gene42, Inc. 

     11.12 Lifeomic Health, LLC 

12 Appendix 

     12.1 Discussion Guide 

     12.2 Knowledge Store: Research Cosmos’ Subscription Portal 

     12.3 Available Customizations 

     12.4 Related Reports 

     12.5 Author Details

List of Tables (66 Tables)

Table 1 Government Initiatives in the Field of Precision Medicine Software

Table 2 Start-Up Companies in the Precision Medicine Software Market

Table 3 Market, By Delivery Mode, 2017–2024 (USD Million)

Table 4 On-Premise Precision Medicine Software Market, By Region, 2017–2024 (USD Million)

Table 5 North America: On-Premise Precision Medicine Software Market, By Country, 2017–2024 (USD Million)

Table 6 Europe: On-Premise Precision Medicine Software Market, By Region, 2017–2024 (USD Million)

Table 7 Cloud-Based Precision Medicine Software Market, By Region, 2017–2024 (USD Million)

Table 8 North America: Cloud-Based Precision Medicine Software Market, By Country, 2017–2024 (USD Million)

Table 9 Europe: Cloud-Based Precision Medicine Software Market, By Region, 2017–2024 (USD Million)

Table 10 Market, By End User, 2017–2024 (USD Million)

Table 11 Market for Healthcare Providers, By Region, 2017–2024 (USD Million)

Table 12 North America: Market for Healthcare Providers, By Country, 2017–2024 (USD Million)

Table 13 Europe: Market for Healthcare Providers, By Country, 2017–2024 (USD Million)

Table 14 Market for Research Centers and Government Institutes, By Region, 2017–2024 (USD Million)

Table 15 North America: Market for Research Centers and Government Institutes, By Country, 2017–2024 (USD Million)

Table 16 Europe: Market for Research Centers and Government Institutes, By Country, 2017–2024 (USD Million)

Table 17 Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)

Table 18 North America: Market for Pharmaceutical and Biotechnology Companies, By Country, 2017–2024 (USD Million)

Table 19 Europe: Market for Pharmaceutical and Biotechnology Companies, By Country, 2017–2024 (USD Million)

Table 20 Market for Other End Users, By Region, 2017–2024 (USD Million)

Table 21 North America: Market for Other End Users, By Country, 2017–2024 (USD Million)

Table 22 Europe: Market for Other End Users, By Country, 2017–2024 (USD Million)

Table 23 Market, By Application, 2017–2024 (USD Million)

Table 24 Market for Oncology, By Region, 2017–2024 (USD Million)

Table 25 North America: Market for Oncology, By Country, 2017–2024 (USD Million)

Table 26 Europe: Market for Oncology, By Region, 2017–2024 (USD Million)

Table 27 Market for Pharmacogenomics, By Region, 2017–2024 (USD Million)

Table 28 North America: Market for Pharmacogenomics, By Country, 2017–2024 (USD Million)

Table 29 Europe: Market for Pharmacogenomics, By Region, 2017–2024 (USD Million)

Table 30 Market for Rare Diseases, By Region, 2017–2024 (USD Million)

Table 31 North America: Market for Rare Diseases, By Country, 2017–2024 (USD Million)

Table 32 Europe: Market for Rare Diseases, By Region, 2017–2024 (USD Million)

Table 33 Market for Other Applications, By Region, 2017–2024 (USD Million)

Table 34 North America: Market for Other Applications, By Country, 2017–2024 (USD Million)

Table 35 Europe: Market for Other Applications, By Region, 2017–2024 (USD Million)

Table 36 Market, By Region, 2017–2024 (USD Million)

Table 37 North America: Market, By Country, 2017–2024 (USD Million)

Table 38 North America: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 39 North America: Market, By End User, 2017–2024 (USD Million)

Table 40 North America: Market, By Application, 2017–2024 (USD Million)

Table 41 US: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 42 US: Market, By End User, 2017–2024 (USD Million)

Table 43 US: Market, By Application, 2017–2024 (USD Million)

Table 44 Canada: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 45 Canada: Market, By End User, 2017–2024 (USD Million)

Table 46 Canada: Market, By Application, 2017–2024 (USD Million)

Table 47 Europe: Market, By Region, 2017–2024 (USD Million)

Table 48 Europe: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 49 Europe: Market, By End User, 2017–2024 (USD Million)

Table 50 Europe: Market, By Application, 2017–2024 (USD Million)

Table 51 Eu5: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 52 Eu5: Market, By End User, 2017–2024 (USD Million)

Table 53 Eu5: Market, By Application, 2017–2024 (USD Million)

Table 54 ROE: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 55 ROE: Market, By End User, 2017–2024 (USD Million)

Table 56 ROE: Market, By Application, 2017–2024 (USD Million)

Table 57 Asia: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 58 Asia: Market, By End User, 2017–2024 (USD Million)

Table 59 Asia: Market, By Application, 2017–2024 (USD Million)

Table 60 RoW: Market, By Delivery Mode, 2017–2024 (USD Million)

Table 61 RoW: Market, By End User, 2017–2024 (USD Million)

Table 62 RoW: Market, By Application, 2017–2024 (USD Million)

Table 63 Solution Launches

Table 64 Expansions

Table 65 Partnerships, Agreements, and Collaborations

Table 66 Acquisitions

List of Figures (23 Figures)

Figure 1 Research Methodology: Precision Medicine Software

Figure 2 Research Design

Figure 3 Sampling Frame: Primary Research

Figure 4 Market Size Estimation Methodology: Bottom-Up Approach

Figure 5 Market Size Estimation Methodology: Top-Down Approach

Figure 6 Data Triangulation Methodology

Figure 7 Market Share, By Delivery Mode, 2018

Figure 8 Market Share, By End User, 2018

Figure 9 Market Share, By Application, 2018

Figure 10 Geographic Snapshot of the Precision Medicine Software Market

Figure 11 Rising Government Funding in Precision Medicine Initiatives to Drive Market Growth During the Forecast Period

Figure 12 On-Premise Delivery Mode Accounted for the Largest Share of the North American Precision Medicine Software Market in 2018

Figure 13 Healthcare Providers Accounted for the Largest Market Share in 2018

Figure 14 North America to Witness the Highest Growth Rate During the Forecast Period

Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges

Figure 16 Market, By Region, 2019 vs. 2024 (USD Million)

Figure 17 North America: Market Snapshot

Figure 18 Europe: Market Snapshot

Figure 19 Asia: Market Snapshot

Figure 20 RoW: Market Snapshot

Figure 21 Key Developments in the Precision Medicine Software Market Between 2016 and 2019

Figure 22 Market Ranking, By Key Player (2018)

Figure 23 Market (Global), Competitive Leadership Mapping, 2018

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?